Liver X Receptor Biology and Therapeutic Applications

Liver X receptors (LXRs) are ligand-activated nuclear transcription factors comprising two isoforms, LXRα and LXRβ, that serve as master regulators of lipid and cholesterol homeostasis. Upon binding oxysterol derivatives of cholesterol, LXRs heterodimerise with retinoid X receptors and orchestrate the expression of genes involved in cholesterol efflux (notably ABCA1 and ABCG1), bile acid synthesis and lipogenesis. Beyond lipid metabolism, LXRs modulate inflammatory pathways in macrophages, maintain vascular and blood–brain barrier integrity, and influence neuronal and glial function. Pharmacological activation of LXRs holds promise for treating atherosclerosis, metabolic syndrome, neurodegenerative disorders and peripheral neuropathies. However, systemic LXR agonism can provoke excessive hepatic triglyceride synthesis and steatosis, prompting the search for selective modulators, tissue-targeted compounds and co-regulator-biased ligands. Advances in structural biology have revealed a flexible ligand-binding pocket amenable to diverse chemical scaffolds, enabling rational design of LXRβ-selective agonists that retain anti-atherogenic and neuroprotective benefits while minimising adverse lipogenic effects. This translational pipeline spans dietary phytosterols and phenolics to synthetic oxysterol mimetics, underscoring the global impact of LXR biology from metabolic health to neuroprotection.

Research from Nature Portfolio

Recent studies have delineated a critical role for LXRs in maintaining peripheral nerve health through oxidative-stress regulation. Genetic ablation of both receptor isoforms in murine models precipitates superoxide accumulation, lipid peroxidation and protein carbonylation in sciatic nerves, accompanied by locomotor deficits. Conversely, pharmacological activation of LXRs in Schwann cells enhances antioxidant defences and preserves myelin integrity under oxidative challenge. These findings position LXR agonism as a viable strategy to combat peripheral demyelinating conditions driven by redox imbalance.

Liver X Receptor Biology and Therapeutic Applications publication trend

The graph below shows the total number of articles in liver x receptor biology and therapeutic applications across all publications each year (not limited to Nature Index journals).

Technical terms

LXRα/LXRβ: Isoforms of the liver X receptor nuclear receptor family that regulate genes controlling cholesterol and lipid homeostasis.

Oxysterols: Oxygenated derivatives of cholesterol that serve as endogenous ligands for LXRs.

Heterodimerisation: The process by which LXRs pair with retinoid X receptors to bind DNA response elements and regulate gene transcription.

Cholesterol efflux: Cellular export of cholesterol mediated by transporters such as ABCA1 and ABCG1, essential for reverse cholesterol transport.

Agonist: A molecule that binds a receptor to activate its signalling function, in this context enhancing LXR-mediated transcription.

References

1. Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2. Cell Death & Disease (2023).
2. Dietary Phenolic Compounds Exert Some of Their Health-Promoting Bioactivities by Targeting Liver X Receptor (LXR) and Retinoid X Receptor (RXR). Foods (2023).
3. Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases. International Journal of Molecular Sciences (2023).
4. The Three-dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-binding Pocket That Can Accommodate Fundamentally Different Ligands*. Journal of Biological Chemistry (2003).
5. Liver X Receptor exerts a protective effect against the oxidative stress in the peripheral nerve. Scientific Reports (2018).
6. Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway*. Journal of Biological Chemistry (1997).